Xanthine Oxidase

Genetic Link to Kidney Disease: XORTX Therapeutics Highlights New Research Supporting Its XO Inhibitor Strategy

XORTX Therapeutics Inc. (NASDAQ: XRTX), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease,...